BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 34273044)

  • 1. "Omics" in traumatic brain injury: novel approaches to a complex disease.
    Abu Hamdeh S; Tenovuo O; Peul W; Marklund N
    Acta Neurochir (Wien); 2021 Sep; 163(9):2581-2594. PubMed ID: 34273044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'Omics' of Epigenetic Modulation by Valproic Acid Treatment in Traumatic Brain Injury-What We Know and What the Future Holds.
    Bhatti UF; Williams AM; Georgoff PE; Alam HB
    Proteomics Clin Appl; 2019 Nov; 13(6):e1900068. PubMed ID: 31441601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics and Biomarker Discovery in Traumatic Brain Injury.
    Banoei MM; Casault C; Metwaly SM; Winston BW
    J Neurotrauma; 2018 Aug; 35(16):1831-1848. PubMed ID: 29587568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for Traumatic Brain Injury: Data Standards and Statistical Considerations.
    Huie JR; Mondello S; Lindsell CJ; Antiga L; Yuh EL; Zanier ER; Masson S; Rosario BL; Ferguson AR;
    J Neurotrauma; 2021 Sep; 38(18):2514-2529. PubMed ID: 32046588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteomic and metabolomic signatures of isolated and polytrauma traumatic brain injury.
    Cralley AL; Erickson C; Schaid TR; Hallas W; Thielen O; Mitra S; Stafford P; Hom P; Silliman C; Cohen MJ; Moore EE; D'Alessandro A; Hansen KC
    Am J Surg; 2023 Dec; 226(6):790-797. PubMed ID: 37541795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TBI Rehabilomics Research: an Exemplar of a Biomarker-Based Approach to Precision Care for Populations with Disability.
    Wagner AK
    Curr Neurol Neurosci Rep; 2017 Sep; 17(11):84. PubMed ID: 28929311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics in severe traumatic brain injury: a scoping review.
    Fedoruk RP; Lee CH; Banoei MM; Winston BW
    BMC Neurosci; 2023 Oct; 24(1):54. PubMed ID: 37845610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omics sciences and precision medicine in melanoma.
    Medori MC; Donato K; Dhuli K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Gisondi P; Bellinato F; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):29-36. PubMed ID: 37994746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics analysis of the hippocampus in a rat model of traumatic brain injury during the acute phase.
    Zheng F; Zhou YT; Feng DD; Li PF; Tang T; Luo JK; Wang Y
    Brain Behav; 2020 Feb; 10(2):e01520. PubMed ID: 31908160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
    Ahmed Z
    Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omics for the future in asthma.
    Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
    Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and Genomics of Acute Neurologic Disorders.
    Maserati M; Alexander SA
    AACN Adv Crit Care; 2018; 29(1):57-75. PubMed ID: 29496714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omics sciences and precision medicine in lung cancer.
    Micheletti C; Dhuli K; Donato K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):37-45. PubMed ID: 37994747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From single- to multi-omics: future research trends in medicinal plants.
    Yang L; Yang Y; Huang L; Cui X; Liu Y
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36416120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omic analysis in injured humans: Patterns align with outcomes and treatment responses.
    Wu J; Vodovotz Y; Abdelhamid S; Guyette FX; Yaffe MB; Gruen DS; Cyr A; Okonkwo DO; Kar UK; Krishnamoorthi N; Voinchet RG; Billiar IM; Yazer MH; Namas RA; Daley BJ; Miller RS; Harbrecht BG; Claridge JA; Phelan HA; Zuckerbraun BS; Johansson PI; Stensballe J; Morrissey JH; Tracy RP; Wisniewski SR; Neal MD; Sperry JL; Billiar TR;
    Cell Rep Med; 2021 Dec; 2(12):100478. PubMed ID: 35028617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury.
    Mondello S; Thelin EP; Shaw G; Salzet M; Visalli C; Cizkova D; Kobeissy F; Buki A
    Expert Rev Proteomics; 2018 May; 15(5):451-461. PubMed ID: 29671356
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.